New nano drug could stop chemo nausea in its tracks
NCT ID NCT07246070
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new form of the drug megestrol acetate (nano-crystalline) combined with a standard anti-nausea medicine to prevent nausea and vomiting caused by chemotherapy. It involves 127 people with stomach cancer who are starting their first chemotherapy. The goal is to see if this combination works better than the current standard treatment (dexamethasone plus the same anti-nausea medicine) over a 21-day period.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can immunotherapy outperform chemo after stomach cancer surgery?
- Could a smartphone program supervised by AI boost recovery after stomach cancer surgery?
- Can stomach cancer surgery also tame diabetes?
- Can a modified stomach bypass speed up recovery in advanced gastric cancer?